Newton Highlands, MA, United States of America

Xin Yan

This inventor holds 1 USPTO granted patent. Top assignee: Moma Therapeutics. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Yan. Retrieved from https://idiyas.com/inventor/xin-yan-8qbwdhx8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xin Yan: Inventor in Biotechnology

Introduction

Xin Yan is an inventor associated with Newton Highlands, Massachusetts, and Moma Therapeutics. His patent work concerns compounds intended to modulate Werner Helicase (WRN) activity, a target implicated in cancer and other disorders.

Latest Patents

Yan is named on 1 patent: “Tricyclic Derivatives and Related Uses.” The disclosure covers compounds of Formula (I′), their prodrugs and pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods of preparation. It describes potential applications in modulating WRN activity and treating disorders in which that activity is implicated, including cancer.

Career Highlights

Yan’s listed patent connects his work at Moma Therapeutics with research into compounds that may affect WRN, a helicase studied as a therapeutic target. The patent describes a range of related compounds and pharmaceutical applications.

Collaborations

Meredeth A. McGowan is identified as a coworker. The patent information provided does not specify her role in the invention or the nature of their collaboration.

Conclusion

Xin Yan’s patent record highlights research into tricyclic compounds and their potential use in modulating WRN activity, including in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…